SHPCX (SHPCX) Stock Price & Analysis
SHPCX (SHPCX) rose 0.68% to USD 14.89 as of July 26, 2026 at 07:07 UTC, according to Nexqual real-time market data.
SHPCX last closed at USD 14.79; the session ranged USD 14.89–14.89 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 12.17–15.2 (NAS). Source: Nexqual, July 26, 2026 at 07:07 UTC.
Key Statistics (as of July 26, 2026 at 07:07 UTC)
| Price | USD 14.89 |
|---|---|
| Change | ▲ 0.68% (up) |
| Previous Close | USD 14.79 |
| Open | USD 14.89 |
| Day Range | USD 14.89 – 14.89 |
| 52-Week Range | USD 12.17 – 15.2 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (SHPCX)
Nexqual's technical model rates SHPCX "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 26, 2026 at 07:07 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 58.42 (neutral) |
| vs SMA50 | Above (USD 14.24) |
| MACD | 0.14 (positive) |
Financial Health Score (SHPCX)
Nexqual rates SHPCX's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 07:07 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SHPAX | Saratoga Advantage Tr Health & | USD 22.81 | ▲ 2.29% |
| SBHIX | Saratoga Advantage Trust: Healt | USD 27.78 | ▲ 2.28% |
| RYCFX | Rydex Biotechnology Fund - C Cl | USD 50.36 | ▲ 0.52% |
| RYOAX | Rydex Series Fds, Biotechnology | USD 67.96 | ▲ 0.53% |
| LOGSX | Live Oak Health Sciences Fund | USD 25.44 | ▲ 2.09% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 07:07 UTC. This page is informational and not investment advice.